- ELITechGroup launches their second kit of the Gastrointestinal infection assay panel targeting parasitic pathogens.
- The ELITe MGB Gastrointestinal assays are IVDR-certified in combination with InGenius and BeGenius, fully automated samples-to-results instruments.
- The company will shortly launch two more gastrointestinal assay infection panels targeting viral pathogens and Norovirus.
ELITechGroup announces the introduction of GI Parasitic PLUS ELITe MGB® Kit, the second addition to its gastrointestinal infection assay portfolio. Designed exclusively for diagnosing gastrointestinal parasitic infections, the kit targets Giardia lamblia, Cryptosporidium spp., Entamoeba histolytica, Encephalitozoon intestinalis, and Enterocytozoon Bieunesi. These pathogens are key contributors to gastrointestinal diseases resulting from food and water contamination, significantly impacting children, immunocompromised individuals, and global travelers.
The kit is validated with ELITe InGenius and ELITe BeGenius sample-to-result instruments and designed to deliver precision diagnostics of human stool specimens. The fully automated process associated with the GI Parasitic PLUS ELITe MGB® Kit, spanning from extraction to result interpretation, has obtained IVDR certification, reaffirming ELITechGroup’s steadfast dedication to upholding the utmost standards of quality.
Last month, ELITechGroup introduced its first kit of the GI infection assay portfolio: the GI Bacterial PLUS ELITe MGB® Kit. The company is geared to launch two additional in vitro diagnostic kits for Gastrointestinal Infections, targeting the viral parasites: the GI Viral PLUS ELITe MGB® Kit and the GI Norovirus PLUS ELITe MGB® Kit.
These forthcoming launches are designed to offer a comprehensive solution for managing life-threatening gastrointestinal infections, marking a significant milestone in ELITechGroup’s mission to deliver state-of-the-art diagnostic solutions.
About ELITechGroup
ELITechGroup is an integrated in-vitro diagnostics company that serves hospitals and diagnostic laboratories in more than 100 countries. The company develops, manufactures, and markets a wide range of diagnostic products and solutions – instruments, reagents, and software.
ELITech Molecular Diagnostics (MDx), one of the four business units of ELITechGroup, serves the needs of clinical and research laboratories by offering a wide range of molecular diagnostic products, including nearly 60 CE-IVD assays and instruments as well as software applications.